Ademi LLP investigates whether Aeterna Zentaris Inc.’s transaction with Ceapro was fair to shareholders

MILWAUKEE, June 7, 2024 /PRNewswire/ — Ademi LLP investigates Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in the transaction with Ceapro.

Click here to learn how you can participate in our investigation: https://www.ademilaw.com/case/aeterna-zentaris-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

In the transaction, each outstanding share of Ceapro common stock was exchanged for 0.09439 shares of Aeterna common stock. In addition, Aeterna issued its shareholders 0.47698 share purchase warrants for each share of Aeterna common stock held. Upon completion of the transaction, former Ceapro shareholders now own 50% of Aeterna and pre-transaction security holders of Aeterna now own the remaining 50%, assuming all warrants are exercised. The transaction may not have been in the best interests of Aeterna shareholders. Insiders will receive significant benefits under the change of control agreements.

We are investigating the conduct of Aeterna’s board of directors and whether it has fulfilled its fiduciary duties to all shareholders.

If you own Aeterna common stock and would like further information, please contact Guri Ademi either at (email protected) or toll-free: 866-264-3995 or https://www.ademilaw.com/case/aeterna-zentaris-inc.

We specialize in shareholder litigation involving takeovers, mergers and individual shareholder rights throughout the country. For more information, please call us. Attorney Advertising. Past results do not guarantee similar results.

contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Never miss a story from Ademi LLP again.